Psychedelics and AI in 2025 with Dillan DiNardo

January 17, 2025

Listen or watch on your favorite platform

Arise Health logo2020INC logoArise Health logo

Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics, AI, consciousness, why Marc Andreessen hates psychedelics, and the intersection of all these things.

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC